Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
regn
/
Regeneron Pharmaceuticals Inc
REGN
Add to Watchlist
651.870
USD
+0.690
+0.11%
Close 07-23 16:00(ET)
Quotes delayed by 15 min
0.000
USD
0.000
Pre-market 07/24, 09:30 (ET)
68.45B
Market Cap
15.34
P/E TTM
Regeneron Pharmaceuticals Inc
651.870
+0.690
+0.11%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Vanguard Capital Management, LLC
6.46%
BlackRock Institutional Trust Company, N.A.
5.27%
State Street Investment Management (US)
4.52%
Dodge & Cox
4.46%
JP Morgan Asset Management
2.94%
Other
76.34%
Shareholders
Shareholders
Proportion
Vanguard Capital Management, LLC
6.46%
BlackRock Institutional Trust Company, N.A.
5.27%
State Street Investment Management (US)
4.52%
Dodge & Cox
4.46%
JP Morgan Asset Management
2.94%
Other
76.34%
Shareholder Types
Shareholders
Proportion
Investment Advisor
47.12%
Investment Advisor/Hedge Fund
32.63%
Hedge Fund
3.44%
Research Firm
2.77%
Pension Fund
2.73%
Individual Investor
2.06%
Bank and Trust
1.91%
Sovereign Wealth Fund
1.34%
Family Office
0.10%
Other
5.91%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
2806
94.67M
91.89%
-1.67M
2025Q4
2703
93.79M
90.28%
-1.94M
2025Q3
2596
94.26M
91.26%
-4.21M
2025Q2
2585
99.72M
95.69%
-2.03M
2025Q1
2621
99.84M
93.97%
-1.42M
2024Q4
2581
100.17M
93.15%
-475.65K
2024Q3
2505
99.81M
90.67%
-1.99M
2024Q2
2479
100.87M
93.10%
+570.24K
2024Q1
2440
99.77M
92.44%
+388.23K
2023Q4
2406
98.50M
91.94%
-617.06K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
5.43M
5.22%
-34.17K
-0.63%
Dec 31, 2025
State Street Investment Management (US)
4.66M
4.49%
-30.41K
-0.65%
Dec 31, 2025
Dodge & Cox
4.60M
4.42%
+45.51K
+1.00%
Dec 31, 2025
JP Morgan Asset Management
3.03M
2.92%
+85.69K
+2.91%
Dec 31, 2025
Geode Capital Management, L.L.C.
2.52M
2.42%
-16.36K
-0.65%
Dec 31, 2025
Fidelity Management & Research Company LLC
2.26M
2.18%
+376.02K
+19.93%
Dec 31, 2025
Putnam Investment Management, L.L.C.
2.26M
2.17%
+109.70K
+5.11%
Dec 31, 2025
Invesco Capital Management (QQQ Trust)
2.20M
2.11%
-53.02K
-2.36%
Feb 28, 2026
Loomis, Sayles & Company, L.P.
1.93M
1.86%
-45.13K
-2.28%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
ProShares Ultra Nasdaq Biotechnology
6.6%
Invesco Nasdaq Biotechnology ETF
6.55%
Amplify Weight Loss Drug & Treatment ETF
6.4%
iShares Biotechnology ETF
5.9%
Simplify Health Care ETF
5.54%
VanEck Biotech ETF
5.51%
Invesco Biotechnology & Genome ETF
5.4%
iShares Genomics Immunology and Healthcare ETF
4.97%
First Trust NASDAQ Pharmaceuticals ETF
4.36%
First Trust NYSE Arca Biotechnology Index Fund
3.88%
View more
ProShares Ultra Nasdaq Biotechnology
Proportion
6.6%
Invesco Nasdaq Biotechnology ETF
Proportion
6.55%
Amplify Weight Loss Drug & Treatment ETF
Proportion
6.4%
iShares Biotechnology ETF
Proportion
5.9%
Simplify Health Care ETF
Proportion
5.54%
VanEck Biotech ETF
Proportion
5.51%
Invesco Biotechnology & Genome ETF
Proportion
5.4%
iShares Genomics Immunology and Healthcare ETF
Proportion
4.97%
First Trust NASDAQ Pharmaceuticals ETF
Proportion
4.36%
First Trust NYSE Arca Biotechnology Index Fund
Proportion
3.88%